Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ATIPAMEZOLE HYDROCH

Closed
SPE2DP-26-T-3494Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract pertains to the procurement of Atipamezole Hydrochloride Injection, a veterinary pharmaceutical specifically formulated for use in dogs to reverse the effects of Medetomidine HCL anesthesia. The product is supplied as a 5 mg/ml solution in a 10 ml multi-dose vial, administered intramuscularly. The item is regulated by the FDA and requires strict adherence to quality and packaging standards, including controlled room temperature storage and labeling in accordance with the latest medical marking standards. The shelf-life for this product is set at 36 months and is non-extendable. The contract calls for the delivery of three vials, with a 20-day delivery schedule to a destination likely associated with Fort Bragg. Inspection and acceptance of the product will occur at the destination, with no quantity variance allowed. Multiple manufacturers and suppliers are referenced, including Patterson Veterinary Supply, Covetrus North America, and Zoetis Inc., indicating multiple approved sources for the item. The contract incorporates defense information handling requirements and follows Department of Defense technical and quality standards. The procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA with Shairy M. Cartagena as the primary point of contact.

General Info

Procurement of three FDA-regulated Atipamezole Hydrochloride Injection vials for canine anesthesia reversal.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

BLDG 4, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3494 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts

Full Description

Show more
ATIPAMEZOLE HYDROCH
ATIPAMEZOLE HYDROCHLORIDE INJECTION, VETERINARY
.
5 MG/ML OF ACTIVE INGREDIENT; 10 ML MULTI-DOSE VIAL;
FOR USE ON DOGS ONLY; USED TO REVERSE THE EFFECTS OF MEDETOMIDINE HCL.
USE INTRAMUSCULAR IN DOGS ONLY.
.
UNIT OF ISSUE: VIAL (VI) OF 10ML.
.
STORE AT CONTROLLED ROOM TEMPERATURE.
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 VI = 10 ML
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-867-7097 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 034363 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 082124 ZOETIS INC. 0M1P3 P/N 10000449
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3494
SECTION B
PR: 7016857050 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016857050 0001 VI 3.000
NSN/MATERIAL:6509014933405
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-493-3405 Quantity: 3 VI Purchase Request: 7016857050QTY: 3 Delivery: 20 days ADO